Pacific Biosciences Of California | PACB - Operating Expenses


Pacific Biosciences Of California reported $74.08M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
General Electric Aerospace USD 10.94B 7.87B Dec/2025
Illumina USD 903M 69M Dec/2025
Myriad Genetics USD 229M 3.4M Sep/2025
Pacific Biosciences Of California USD 74.08M 107.7M Sep/2024
Quidel USD 760.9M 1.28B Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Standard Biotools USD 43.02M 2.44M Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Waters USD 661.85M 1.67B Dec/2025